Nippon Shokubai Co., Ltd.

Nippon Shokubai to Boost Nucleic Acid Drug API Output Tenfold

Nippon Shokubai recently announced plans to expand its GMP-compliant manufacturing capacity for nucleic acid drug active pharmaceutical ingredients (APIs) tenfold.